Terms: = Bone cancer AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791 AND Treatment
3 results:
1. Impact of Genetic Polymorphisms in NF-ĸB2 and TRAF3 Genes on Response to Bortezomib-Based Therapy in Multiple Myeloma Patients.
Sood N; Hamide A; Dubashi B; Nisha Y; Mathaiyan J; Munirajan AK; Ganesn P; Kayal S
Asian Pac J Cancer Prev; 2024 Mar; 25(3):829-837. PubMed ID: 38546066
[TBL] [Abstract] [Full Text] [Related]
2. Lactate Decreases Bortezomib Sensitivity and Predicts Poor Clinical Outcomes of Multiple Myeloma.
Ma NY; Li Q; Li XL; Zeng YJ; Huang DZ; Duan YS; Xia J; Liu BD; Rao LY; Rao J; Zhang X
Curr Med Sci; 2023 Aug; 43(4):679-688. PubMed ID: 37326888
[TBL] [Abstract] [Full Text] [Related]
3. Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma.
Sollazzo V; Galasso M; Volinia S; Carinci F
J Orthop Res; 2012 Jun; 30(6):1004-12. PubMed ID: 22147650
[TBL] [Abstract] [Full Text] [Related]
